InvestorsHub Logo
Followers 0
Posts 7
Boards Moderated 0
Alias Born 07/12/2017

Re: None

Tuesday, 07/25/2017 10:37:46 AM

Tuesday, July 25, 2017 10:37:46 AM

Post# of 18649
Any none what the the weight of this news could possibly mean for the future of soon to be GT Pharma???

ITEM 5.03 Amendment to Certificate of Incorporation.
On July 17, 2017, the Registrant amended its Certificate of Incorporation for the purpose of changing the name of the Registrant from Oxis International, Inc. to GT Biopharma, Inc. The amendment also made other changes to the Certificate of Incorporation as described in the definitive information statement filed by the Registrant with the Securities and Exchange Commission on May 12, 2017.
ITEM 8.01 Other Events.
On July 25, 2017, the Registrant issued a press release giving additional details about its plans to acquire Georgetown Translational Pharmaceuticals, Inc. which was originally announced on June 26, 2017. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. A slide deck giving additional details about the acquisition and how it will add value to the Registrant is attached hereto as Exhibit 99.2 and is also incorporated herein by reference.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTBP News